Impact of TNF inhibitor medication on working ability in axial spondyloarthritis: an observational national registry-based cohort study.

MLA

Hokkanen, Anna-Mari, et al. “Impact of TNF Inhibitor Medication on Working Ability in Axial Spondyloarthritis: An Observational National Registry-Based Cohort Study.” Rheumatology Advances in Practice, vol. 7, no. 2, May 2023, p. rkad050. EBSCOhost, https://doi.org/10.1093/rap/rkad050.

APA

Hokkanen, A.-M., Aaltonen, K., Relas, H., Rutanen, J., Kononoff, A., Taimen, K., Kauppi, M., Puolakka, K., Trokovic, N., & Nordström, D. (2023). Impact of TNF inhibitor medication on working ability in axial spondyloarthritis: an observational national registry-based cohort study. Rheumatology Advances in Practice, 7(2), rkad050. https://doi.org/10.1093/rap/rkad050

Chicago

Hokkanen, Anna-Mari, Kalle Aaltonen, Heikki Relas, Jarno Rutanen, Aulikki Kononoff, Kirsi Taimen, Markku Kauppi, Kari Puolakka, Nina Trokovic, and Dan Nordström. 2023. “Impact of TNF Inhibitor Medication on Working Ability in Axial Spondyloarthritis: An Observational National Registry-Based Cohort Study.” Rheumatology Advances in Practice 7 (2): rkad050. doi:10.1093/rap/rkad050.